- 歐洲藥品管理局表示,強生公司的新冠疫苗應將罕見血栓伴隨低血小
板列為非常罕見的潛在副作用。該機構還表示, 強生公司新冠疫苗的總體好處仍大於潛在副作用的風險。
***
Coronavirus latest: Australia seeks to build mRNA vaccine plant
The report comes as more nations are vying for jabs from Pfizer and Moderna, which use a novel mRNA technology that has been proven safe and highly effective.
Japan Cuts Reliance on AstraZeneca Vaccine with More Pfizer Jabs
Japan is poised to buy more doses of the Covid-19 vaccine dev
***
Patients are dying while their families search in vain for hospital beds.
大阪必須要即刻因應了!
https://www.nippon.com/hk/news/kd757066542061223936/
NIPPON.COM
疫情危急!大阪府20日下午將要求發佈「緊急事態宣言」
【共同社4月20日電】鑑於新冠病毒傳染病的重症患者激增導致醫療供應體制告急,日本大阪府20日下午將召開對策總部…
***
The Southeast Asian nation is expecting as many as 14 million vaccine doses this quarter.
Across Southeast Asia, companies are moving to import COVID shots and vaccinate their employees for free as new surges of infections threaten operations already disrupted by the pandemic.
BLOOMBERG.COM
Philippines Clears Covid Vaccines From J&J, India’s Bharat Biotech
The Philippines has authorized the emergency use of Johnson & Johnson’s single-shot coronavirus vaccine days after the U.S. suspended use due to a rare side effect.
We must work together to vaccinate people because of need, not because of borders, only then can we get back to what we love. #OnlyTogether
Philippines Clears Covid Vaccines From J&J, India’s Bharat Biotech
The Philippines has authorized the emergency use of Johnson & Johnson’s single-shot coronavirus vaccine days after the U.S. suspended use due to a rare side effect.
We must work together to vaccinate people because of need, not because of borders, only then can we get back to what we love. #OnlyTogether
沒有留言:
張貼留言